Results 191 to 200 of about 131,349 (275)

Real-World Evidence of Combination Therapy Use in Metastatic Hormone-Sensitive Prostate Cancer in the United States From 2017 to 2023. [PDF]

JCO Oncol Pract
Raval AD, Lunacsek O, Korn MJ, Littleton N, Constantinovici N, George DJ.   +5 more
europepmc   +1 more source

Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti‐inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies

Animal Models and Experimental Medicine, EarlyView.
Adenostemma lavenia, a traditionally used medicinal plant, has been employed to manage pain, inflammation, and circulatory issues. This study investigates the analgesic, anti‐inflammatory, and thrombolytic potentials of the acetone extract of A. lavenia leaves (AEAL) using in vivo, in vitro, and in silico methods.
Nusrat Jahan Moon, Mahathir Mohammad, Md. Jahirul Islam Mamun, Fahmina Binty Azim Nova, Nazmul Hasan Eshaque, Md. Hossain Rasel, Zobayed Islam, Md. Mahmudul Hasan, Md. Liakot Ali, Md. Tanvir Chowdhury, S. M. Moazzem Hossen   +10 more
wiley   +1 more source

Impact of treatment patterns and sequencing on clinical and economic outcomes in patients with metastatic urothelial cancer: IMPACT UC II study. [PDF]

Oncologist
Bilen MA, Diessner B, White J, Murphy L, Nguyen A, Kirker M, Gharibian N, Morris V, Bhanegaonkar A.   +8 more
europepmc   +1 more source

Cancer therapy‐induced ototoxicity: Current challenges and emerging management strategies

Animal Models and Experimental Medicine, EarlyView.
This review comprehensively examines the key risk factors for cancer therapy‐induced ototoxicity, including cumulative drug dose, genetic susceptibility, and combined treatment regimens. It highlights current challenges in ototoxicity monitoring, such as insufficient timeliness and limited clinical adoption, and advocates for standardized auditory ...
Yuqi Huang, Baoying Xu, Xinru Chen, Yu Chen, Dehong Yu   +4 more
wiley   +1 more source

Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials. [PDF]

Clin Cancer Res
Gerber DE, Wynters CR, Prasad T, Schnel RK, Zhang S, Stinchcombe TE, Villaruz LC, Bauml JM, Iams WT, Patil T, Liu SV, Horn L, Hudak JM, Camidge DR.   +13 more
europepmc   +1 more source

Digitalized human resources for health information systems in low- and middle-income countries: a scoping review. [PDF]

Hum Resour Health
Nagai M, Mufwaya-Nsene R, Thandar MM, Matsuoka S, Okawa S, Fujita N.   +5 more
europepmc   +1 more source

Shared Capitalism at Work: Employee Ownership, Profit and Gain Sharing, and Broad-based Stock Options [PDF]

Douglas L. Kruse, Joseph R. Blasi, Rhokeun Park   +2 more
core  

Optimized Selenium‐Doped Nanocomposites for Enhanced Polymer Gel Performance in Permeability Reduction

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Excessive water production in mature oil fields necessitates robust shut‐off treatments, yet conventional polymer gels often fail under high‐temperature and high‐salinity conditions. This study aims to enhance gel thermal stability and mechanical strength by incorporating selenium‐doped Ag/AgO–ZnO nanocomposites synthesized via a novel green ...
Fadhil F. Sead, Farag M. A. Altalbawy, M. Sudhakara Reddy, Badri Narayan Sahu, Sridharan Sundharam, Sanjeev Kumar, Atreyi Pramanik, Aseel Smerat, Fatimah Pashtun   +8 more
wiley   +1 more source

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients. [PDF]

Oncotarget
El-Deiry WS, Bresson C, Wunder F, Carneiro BA, Dizon DS, Warner JL, Graff SL, Azzoli CG, Wong ET, Cheng L, Mani SA, Safran HP, Williams C, Meissner T, Solomon B, Rubin E, Porgador A, Berchem G, Saintigny P, Onn A, Bar J, Berger R, Gantenbein M, Chen Z, Souza CP, Reis RMV, Sekacheva M, Cervantes A, Dahut WL, Annunziata CM, Gober K, Musallam KM, Al-Shamsi HO, Abu-Gheida I, Salazar R, Limaye S, Aref AT, Reddel RR, Homsi MUA, Rouf A, Dermime S, Suwaidi JA, Vlad C, Buiga R, Omari AA, Abdel-Razeq H, Oñate-Ocaña LF, Nielsen FC, Graham L, Rueter J, Joshua AM, Girda E, Libutti S, Riedlinger G, Salem ME, Farhangfar CJ, Mesa RA, Faltas BM, Elemento O, Pramesh CS, Sengar M, Aoyama S, Ikeda S, Berindan-Neagoe I, Gaddipati H, Kulkarni M, Auzias E, Gerogianni M, Wolikow N, Istolainen S, Schlafrig P, Frankel NZ, Ferraro AR, Palma J, Gimenez AP, Hernando-Calvo A, Felip E, Tsimberidou AM, Herbst RS, Tabernero J, Schilsky RL, Liu J, Lussier Y, Raynaud J, Batist G, Magidi S, Kurzrock R.   +86 more
europepmc   +1 more source

Employee stock option grants and firm performance in the Netherlands. [PDF]

Duffhues, P.J.W., Kabir, M.R., Mertens, G.M.H., Roosenboom, P.G.J.   +3 more
core   +1 more source